| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 8 |
| NetGPI | no | yes: 0, no: 8 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005634 | nucleus | 5 | 7 |
| GO:0043226 | organelle | 2 | 8 |
| GO:0043227 | membrane-bounded organelle | 3 | 7 |
| GO:0043229 | intracellular organelle | 3 | 8 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 7 |
| GO:0110165 | cellular anatomical entity | 1 | 8 |
| GO:0005730 | nucleolus | 5 | 1 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HHF0
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000122 | negative regulation of transcription by RNA polymerase II | 8 | 1 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
| GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
| GO:0006364 | rRNA processing | 8 | 1 |
| GO:0006396 | RNA processing | 6 | 1 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009889 | regulation of biosynthetic process | 4 | 1 |
| GO:0009890 | negative regulation of biosynthetic process | 5 | 1 |
| GO:0009892 | negative regulation of metabolic process | 4 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0010468 | regulation of gene expression | 5 | 1 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 1 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
| GO:0016070 | RNA metabolic process | 5 | 1 |
| GO:0016072 | rRNA metabolic process | 7 | 1 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
| GO:0019222 | regulation of metabolic process | 3 | 1 |
| GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
| GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
| GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 1 |
| GO:0034470 | ncRNA processing | 7 | 1 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
| GO:0034660 | ncRNA metabolic process | 6 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0045892 | negative regulation of DNA-templated transcription | 7 | 1 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
| GO:0046483 | heterocycle metabolic process | 3 | 1 |
| GO:0048519 | negative regulation of biological process | 3 | 1 |
| GO:0048523 | negative regulation of cellular process | 4 | 1 |
| GO:0050789 | regulation of biological process | 2 | 1 |
| GO:0050794 | regulation of cellular process | 3 | 1 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
| GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
| GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
| GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
| GO:0065007 | biological regulation | 1 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:0080090 | regulation of primary metabolic process | 4 | 1 |
| GO:0090304 | nucleic acid metabolic process | 4 | 1 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
| GO:1902679 | negative regulation of RNA biosynthetic process | 7 | 1 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
| GO:1903507 | negative regulation of nucleic acid-templated transcription | 8 | 1 |
| GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 8 |
| GO:0003677 | DNA binding | 4 | 8 |
| GO:0005488 | binding | 1 | 9 |
| GO:0043167 | ion binding | 2 | 8 |
| GO:0043169 | cation binding | 3 | 8 |
| GO:0046872 | metal ion binding | 4 | 8 |
| GO:0097159 | organic cyclic compound binding | 2 | 8 |
| GO:1901363 | heterocyclic compound binding | 2 | 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.606 |
| CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.636 |
| CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.555 |
| CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.514 |
| CLV_PCSK_PC1ET2_1 | 292 | 294 | PF00082 | 0.514 |
| CLV_PCSK_SKI1_1 | 156 | 160 | PF00082 | 0.723 |
| CLV_PCSK_SKI1_1 | 168 | 172 | PF00082 | 0.645 |
| CLV_PCSK_SKI1_1 | 289 | 293 | PF00082 | 0.501 |
| DEG_SCF_TRCP1_1 | 271 | 276 | PF00400 | 0.400 |
| DOC_MAPK_gen_1 | 136 | 145 | PF00069 | 0.676 |
| DOC_MAPK_MEF2A_6 | 136 | 145 | PF00069 | 0.697 |
| DOC_PP2B_LxvP_1 | 237 | 240 | PF13499 | 0.578 |
| DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.662 |
| DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.587 |
| DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.530 |
| DOC_USP7_MATH_1 | 172 | 176 | PF00917 | 0.607 |
| DOC_USP7_MATH_1 | 305 | 309 | PF00917 | 0.467 |
| DOC_USP7_UBL2_3 | 280 | 284 | PF12436 | 0.612 |
| DOC_USP7_UBL2_3 | 292 | 296 | PF12436 | 0.387 |
| DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.500 |
| DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.677 |
| DOC_WW_Pin1_4 | 192 | 197 | PF00397 | 0.704 |
| DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.650 |
| LIG_14-3-3_CanoR_1 | 140 | 146 | PF00244 | 0.575 |
| LIG_14-3-3_CanoR_1 | 241 | 245 | PF00244 | 0.599 |
| LIG_14-3-3_CanoR_1 | 293 | 299 | PF00244 | 0.505 |
| LIG_14-3-3_CanoR_1 | 70 | 78 | PF00244 | 0.591 |
| LIG_FHA_1 | 233 | 239 | PF00498 | 0.634 |
| LIG_FHA_1 | 277 | 283 | PF00498 | 0.529 |
| LIG_FHA_2 | 255 | 261 | PF00498 | 0.515 |
| LIG_FHA_2 | 29 | 35 | PF00498 | 0.366 |
| LIG_FHA_2 | 50 | 56 | PF00498 | 0.308 |
| LIG_LIR_Gen_1 | 28 | 38 | PF02991 | 0.334 |
| LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.334 |
| LIG_MAD2 | 70 | 78 | PF02301 | 0.516 |
| LIG_MYND_1 | 236 | 240 | PF01753 | 0.629 |
| LIG_SH2_STAP1 | 290 | 294 | PF00017 | 0.440 |
| LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.464 |
| LIG_SH3_3 | 10 | 16 | PF00018 | 0.390 |
| LIG_SH3_3 | 159 | 165 | PF00018 | 0.703 |
| LIG_SH3_3 | 186 | 192 | PF00018 | 0.663 |
| LIG_SH3_3 | 224 | 230 | PF00018 | 0.806 |
| LIG_SH3_4 | 15 | 22 | PF00018 | 0.437 |
| LIG_TRAF2_1 | 257 | 260 | PF00917 | 0.519 |
| LIG_TRAF2_1 | 52 | 55 | PF00917 | 0.389 |
| LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.348 |
| LIG_WRC_WIRS_1 | 250 | 255 | PF05994 | 0.495 |
| MOD_CDK_SPxxK_3 | 176 | 183 | PF00069 | 0.549 |
| MOD_CK1_1 | 144 | 150 | PF00069 | 0.569 |
| MOD_CK1_1 | 272 | 278 | PF00069 | 0.551 |
| MOD_CK1_1 | 315 | 321 | PF00069 | 0.410 |
| MOD_CK1_1 | 49 | 55 | PF00069 | 0.337 |
| MOD_CK1_1 | 66 | 72 | PF00069 | 0.552 |
| MOD_CK2_1 | 254 | 260 | PF00069 | 0.506 |
| MOD_CK2_1 | 49 | 55 | PF00069 | 0.367 |
| MOD_CK2_1 | 92 | 98 | PF00069 | 0.551 |
| MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.695 |
| MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.775 |
| MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.660 |
| MOD_GlcNHglycan | 271 | 274 | PF01048 | 0.549 |
| MOD_GlcNHglycan | 307 | 310 | PF01048 | 0.502 |
| MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.647 |
| MOD_GSK3_1 | 116 | 123 | PF00069 | 0.593 |
| MOD_GSK3_1 | 141 | 148 | PF00069 | 0.696 |
| MOD_GSK3_1 | 172 | 179 | PF00069 | 0.637 |
| MOD_GSK3_1 | 269 | 276 | PF00069 | 0.572 |
| MOD_GSK3_1 | 315 | 322 | PF00069 | 0.539 |
| MOD_GSK3_1 | 45 | 52 | PF00069 | 0.339 |
| MOD_GSK3_1 | 93 | 100 | PF00069 | 0.665 |
| MOD_N-GLC_1 | 269 | 274 | PF02516 | 0.383 |
| MOD_N-GLC_1 | 66 | 71 | PF02516 | 0.523 |
| MOD_N-GLC_2 | 23 | 25 | PF02516 | 0.389 |
| MOD_N-GLC_2 | 7 | 9 | PF02516 | 0.458 |
| MOD_NEK2_1 | 269 | 274 | PF00069 | 0.507 |
| MOD_NEK2_2 | 130 | 135 | PF00069 | 0.556 |
| MOD_NEK2_2 | 273 | 278 | PF00069 | 0.484 |
| MOD_OFUCOSY | 25 | 32 | PF10250 | 0.420 |
| MOD_PKA_1 | 204 | 210 | PF00069 | 0.716 |
| MOD_PKA_2 | 240 | 246 | PF00069 | 0.600 |
| MOD_Plk_1 | 150 | 156 | PF00069 | 0.588 |
| MOD_Plk_2-3 | 97 | 103 | PF00069 | 0.664 |
| MOD_Plk_4 | 130 | 136 | PF00069 | 0.596 |
| MOD_Plk_4 | 249 | 255 | PF00069 | 0.497 |
| MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.677 |
| MOD_ProDKin_1 | 192 | 198 | PF00069 | 0.709 |
| MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.650 |
| TRG_DiLeu_BaEn_3 | 259 | 265 | PF01217 | 0.503 |
| TRG_DiLeu_LyEn_5 | 233 | 238 | PF01217 | 0.520 |
| TRG_NLS_Bipartite_1 | 155 | 172 | PF00514 | 0.535 |
| TRG_NLS_MonoCore_2 | 13 | 18 | PF00514 | 0.379 |
| TRG_NLS_MonoExtN_4 | 165 | 172 | PF00514 | 0.621 |
| TRG_Pf-PMV_PEXEL_1 | 284 | 288 | PF00026 | 0.488 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PGN4 | Leptomonas seymouri | 53% | 100% |
| A0A3Q8IRD2 | Leishmania donovani | 70% | 100% |
| A4HHF1 | Leishmania braziliensis | 99% | 100% |
| A4I4K0 | Leishmania infantum | 71% | 100% |
| C9ZL83 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
| E9ADZ9 | Leishmania major | 72% | 98% |
| E9ALT2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 70% | 100% |